DLPL Introduces Advanced Complement Testing in India

Dr. Lal PathLabs (DLPL), one of India’s most prominent diagnostic networks, has introduced the country’s first specialized Complement Testing Laboratory, reinforcing its leadership in autoimmune diagnostics. This state-of-the-art facility offers advanced complement assays—many never before available in India—enabling doctors to detect autoimmune, kidney-related, and recurrent infection disorders with greater speed, precision, and at much earlier stages.Across India, autoimmune and inflammatory conditions are being identified more frequently, yet patients often struggle with vague and overlapping symptoms such as fever, fatigue, joint pain, swelling, or kidney issues. As a result, many individuals visit several specialists before receiving a definitive diagnosis. These delays are common because autoimmune disorders can quietly damage vital organs long before symptoms become evident. Complement testing plays an essential role in uncovering hidden immune dysfunction, helping clinicians understand the root cause of such symptoms and facilitating timely, accurate treatment.The complement system comprises a network of blood proteins that protect the body by fighting infections, removing damaged cells, and maintaining organ health. When these proteins are deficient, individuals—particularly children—may suffer from recurrent or severe infections. Conversely, when the complement system becomes excessively active, it can attack healthy tissues and contribute to diseases such as lupus, vasculitis, rheumatoid arthritis, C3 glomerulopathy, atypical hemolytic uremic syndrome (aHUS), transplant rejection, and severe infections like sepsis.